Drama therapy tames teen aggression in pilot trial
NCT ID NCT07311174
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a 10-session psychodrama program could reduce aggressive behavior and improve social adjustment in 22 male adolescents aged 11-13 who had high aggression scores. Half the teens took part in weekly role-play therapy sessions, while the other half received no treatment. Researchers measured changes using standard questionnaires before and after the program.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
psychodrama (a type of group therapy using role-play and drama techniques)
What this could lead to
If it works, this could offer a low-cost, non-drug way to help teens manage aggression and improve social skills.
What could go wrong
This was a very small study (22 participants) in one region, so results may not apply broadly. The control group received no intervention, which can bias outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGGRESSIVE BEHAVIOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kerman University of Medical Sciences
Kerman, 123456789, Iran